Anonymous User
Login / Registration

Gastroenterologie
a hepatologie

Gastroenterology and Hepatology

Gastroent Hepatol 2011; 65(2): 90-93.

Quantitative testing in colorectal cancer screening - a view of the near future

Jaroslava Tereza Kovářová Orcid.org  1

+ Affiliation

Summary

The author offers a systematic account of the new generation of quantitative immunochemical fecal occult blood tests, and outlines a scheme for their integration into the existing Czech program that screens for colorectal cancer. The characteristics of the quantitative immunochemical test (q-FIT) are described, as well as the types of the fecal occult test (FOBT), and their advantages and disadvantages, together with possible ways of the incorporating q-FIT into the colorectal cancer screening program in the Czech Republic. The inclusion of q-FIT in the Czech colorectal cancer screening program, combined with the existing primary screening colonoscopy, could make a contribution to effectiveness.

Keywords

colorectal cancer, screening, screening, occult blood

To read this article in full, please register for free on this website.

Benefits for subscribers

Benefits for logged users

Print

Credited self-teaching test

Start test

Most Read (last 6 month)

  1. Colorectal cancer screening in the Czech Republic
  2. Pancreatic cancer surveillance in high-risk individuals Position statement of professional societies
  3. Trends in premature mortality from digestive system cancers in Slovakia in the years 2011–2020: 8 diagnoses over 10 years
  4. Results from the evaluation of colorectal cancer screening in the Czech Republic
  5. Mixed adenoneuroendocrine carcinoma of the stomach – a case report
  6. Subcutaneous infliximab in the treatment of refractory Crohn‘s disease patients – a pilot study of drug immunogenicity
  7. Urolithiasis in patients with inflammatory bowel disease – possibilities of prevention and metabolic influence
  8. Subcutaneous infliximab – treatments and new possibilities after clinical practice